Tobacco Use Decreases Visual Sensitivity in Schizophrenia
- PMID: 29559947
- PMCID: PMC5845747
- DOI: 10.3389/fpsyg.2018.00288
Tobacco Use Decreases Visual Sensitivity in Schizophrenia
Abstract
Smoking prevalence in patients who are diagnosed with schizophrenia (SCZ) is higher than in the general population. Chronic tobacco use in SCZ patients may reduce the side effects of antipsychotic drugs, thus serving as a self-medication for such side effects. Understanding the ways in which chronic tobacco use influences visual sensitivity has clinical implications, which may serve as a tool for non-invasively diagnosing early-stage visual processing deficits. The present study evaluated the effects of chronic tobacco use on visual sensitivity in SCZ patients. Our purpose was to provide new directions for future research, mainly psychophysical and electrophysiological studies. In the present study, 40 smoker controls (SC), 20 SCZ tobacco users, and 20 SCZ tobacco nonusers were recruited from the Psychosocial Care Center. Visual sensitivity was compared between both SCZ groups and the SC group. Patients with SCZ who were chronic tobacco users presented lower visual sensitivity for chromatic (p < 0.001) and achromatic (p < 0.001) stimuli compared with the other groups. Our findings highlight the need to evaluate possible addictive behavior in patients with SCZ, which may contribute to public policies that seek to improve the quality of life of SCZ patients and their families.
Keywords: perception; public health; schizophrenia; smoking; tobacco addiction; visual sensitivity.
Figures





Similar articles
-
A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.Biol Psychiatry. 2013 Sep 15;74(6):436-43. doi: 10.1016/j.biopsych.2013.03.017. Epub 2013 May 6. Biol Psychiatry. 2013. PMID: 23660272 Free PMC article.
-
Visual processing and BDNF levels in first-episode schizophrenia.Psychiatry Res. 2021 Nov;305:114200. doi: 10.1016/j.psychres.2021.114200. Epub 2021 Sep 1. Psychiatry Res. 2021. PMID: 34653830
-
Smoking affects the association between cognitive impairment and P50 inhibition defects in patients with chronic schizophrenia: A case-control study.Asian J Psychiatr. 2023 Jan;79:103391. doi: 10.1016/j.ajp.2022.103391. Epub 2022 Dec 5. Asian J Psychiatr. 2023. PMID: 36516649
-
Comorbid schizophrenia and substance abuse: a review of epidemiology and course.Am J Addict. 2006 Sep-Oct;15(5):345-55. doi: 10.1080/10550490600860114. Am J Addict. 2006. PMID: 16966190 Review.
-
Overview of schizophrenia research and treatment in Pakistan.Heliyon. 2020 Nov 23;6(11):e05545. doi: 10.1016/j.heliyon.2020.e05545. eCollection 2020 Nov. Heliyon. 2020. PMID: 33294688 Free PMC article. Review.
Cited by
-
Spatial contrast sensitivity: effects of reliability, test-retest repeatability and sample size using the Metropsis software.Eye (Lond). 2019 Oct;33(10):1649-1657. doi: 10.1038/s41433-019-0477-0. Epub 2019 Jun 5. Eye (Lond). 2019. PMID: 31165771 Free PMC article.
-
Smoking and attention in schizophrenia spectrum disorders: What are we neglecting?Front Psychol. 2023 Mar 30;14:1114473. doi: 10.3389/fpsyg.2023.1114473. eCollection 2023. Front Psychol. 2023. PMID: 37063581 Free PMC article.
-
Study investigating executive function in schizophrenia patients and their unaffected siblings.PLoS One. 2023 Apr 26;18(4):e0285034. doi: 10.1371/journal.pone.0285034. eCollection 2023. PLoS One. 2023. PMID: 37099556 Free PMC article.
-
Combined influence of illness duration and medication type on visual sensitivity in schizophrenia.Braz J Psychiatry. 2020 Jan-Feb;42(1):27-32. doi: 10.1590/1516-4446-2018-0331. Braz J Psychiatry. 2020. PMID: 31269094 Free PMC article.
-
Effects of Nicotine Gum Administration on Vision (ENIGMA-Vis): Study Protocol of a Double-Blind, Randomized, and Controlled Clinical Trial.Front Hum Neurosci. 2020 Sep 8;14:314. doi: 10.3389/fnhum.2020.00314. eCollection 2020. Front Hum Neurosci. 2020. PMID: 33100983 Free PMC article.
References
-
- American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Washington, DC: American Psychiatric Publishing, Inc; 10.1176/appi.books.9780890425596 - DOI
-
- American Psychiatric Association (2015). Structured Clinical Interview for DSM-5 (SCID-5). Washington, DC: American Psychiatric Association.
LinkOut - more resources
Full Text Sources
Other Literature Sources